The companies deployed the HIPAA/GDPR compliant encrypted messaging platform to stop the use of consumer-grade messaging apps and streamline internal and patient communications CHICAGO, Nov. 17, 2021 (GLOBE NEWSWIRE) — NetSfere, a global provider of next-generation secure and compliant messaging and mobility solutions, today announces its partnership with Deutsche Telekom,

Survey finds international students rebound as women and U.S. underrepresented groups flock to full-time MBA programs RESTON, Va., Nov. 17, 2021 (GLOBE NEWSWIRE) — The Graduate Management Admission Council™ (GMAC™), a global association of leading graduate business schools, today released its anticipated annual 2021 Application Trends Survey. The survey of

QUEBEC CITY, Nov. 17, 2021 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce its participation as a host and co-presenter at various events in December. These events will showcase LeddarTech’s comprehensive end-to-end technology platforms,

New Orleans, LA /New York, NY, Nov. 16, 2021 (GLOBE NEWSWIRE) — New Orleans, LA/ New York, NY –Trahan Architects, a global architecture firm with studios in New Orleans and New York City, announced today that its founder and CEO, Victor F. “Trey” Trahan, III, FAIA, has been selected as

Game-changing solutions built on the unique domain expertise of the technology and market leader in power grids which integrate with Hitachi’s Lumada platform Zurich, Switzerland, Nov. 16, 2021 (GLOBE NEWSWIRE) — Zurich, Switzerland, 16 November, 2021 – Further to its press release on October 13, 2021, announcing its evolution to

DENVER, Nov. 16, 2021 (GLOBE NEWSWIRE) — Ensign-Bickford Industries, Inc. (EBI) today announced it has successfully closed on its acquisition of Cawood Scientific Limited (Cawood), headquartered in Bracknell, UK. Headquartered in Denver, CO, EBI is a 185-year-old privately held corporation with diversified businesses in aerospace and defense, molecular diagnostics, and

FDA Feedback Supports Planned Emergency Use Authorization (EUA) Submission for ADG20 for Prevention of COVID-19; Interim Clinical Data Package from EVADE Prevention Trial to Support EUA Submission Expected in Second Quarter 2022 Enrollment Progressing in ADG20 STAMP Trial for Treatment of COVID-19; Planned Interim Efficacy Analysis Expected in Second Quarter

Despite High Confidence in Their Risk Assessment Capabilities, Study Finds a Third of Companies Have Been Breached, and 89% Have Been Hit Multiple Times Philadelphia, Pennsylvania, Nov. 11, 2021 (GLOBE NEWSWIRE) –New data released today by Cornell University’s Center for Hospitality Research and FreedomPay, a global leader in data-driven commerce,